Robust LDL-C Reduction With Alirocumab in Patients Who Tolerate Only Lowest Statin Doses

Hypercholesterolemic patients who tolerate only lowest-dose statin or non-statin lipid lowering therapy can achieve LDL-C reduction with alirocumab.

Source link

Related posts

Aortic root in competitive sports: eyes on the older athlete


Hayden’s Heart Monthly Beat- JUNE


Mechanical Support in Early Cardiogenic Shock: What Is the Role of Intra-aortic Balloon Counterpulsation?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World